Assisted Suicide in Parkinsonian Disorders [PDF]
Frontiers in Neurology, 2021 Background: Due to the high prevalence of suicidal ideation in Parkinson's Disease (PD) and exploratory data indicating a similar prevalence in atypical Parkinsonian disorders (APD), we sought to determine the frequency of assisted suicide (AS) as well ...
Georg S. Nuebling +5 more
doaj +4 more sources
Pseudobulbar Affect in Parkinsonian Disorders: A Review [PDF]
Journal of Movement Disorders, 2019 Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological conditions, including parkinsonian disorders.
Mathew Hakimi, Carine W. Maurer
doaj +4 more sources
Neuropsychiatric disturbances in atypical parkinsonian disorders [PDF]
Neuropsychiatric Disease and Treatment, 2018 Daniele Belvisi,1 Isabella Berardelli,2 Antonio Suppa,1,3 Andrea Fabbrini,3 Massimo Pasquini,3 Maurizio Pompili,2 Giovanni Fabbrini1,3 1IRCCS Neuromed, Pozzilli, Italy; 2Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention ...
Belvisi D +6 more
doaj +3 more sources
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease [PDF]
Nature Aging, 2023 The diagnosis of Parkinsonian disorders is currently based on clinical criteria, which have limited sensitivity until most dopaminergic neurons are lost.
Sara Hall, Oskar Hansson, Erik Stomrud
exaly +5 more sources
Low dose Amantadine and Escitalopram combination in Atypical Parkinsonian disorders- A Retrospective chart review [PDF]
European Psychiatry, 2023 Introduction The response to conventional antiparkinsonian medications is elusive in atypical parkinsonian disorders. Improvement in parkinsonian symptoms in atypical parkinsonian disorders has been reported with anecdotal use of Amantadine. The role of
S. M. Tripathi, P. Chutia
doaj +2 more sources
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot? [PDF]
Brain Sciences, 2022 Neurodegenerative parkinsonian disorders are characterized by a great diversity of clinical symptoms and underlying neuropathology, yet differential diagnosis during lifetime remains probabilistic.
Stéphane Prange +3 more
doaj +2 more sources
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders [PDF]
Journal of Parkinson’s Disease, 2022 Background: Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) present with similar movement disorder symptoms but distinct protein aggregates upon pathological examination.
Shaochun Zhu +3 more
doaj +2 more sources
Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study [PDF]
Frontiers in Neurology, 2019 Background: Convergence insufficiency (CI) in parkinsonian conditions causes disabling visual symptoms during near tasks and usually manifests as double vision.
Samantha K. Holden +3 more
doaj +2 more sources
NeuroImage: Clinical, 2022 Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes.
Trina Mitchell +18 more
doaj +1 more source
The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
Frontiers in Neurology, 2020 The diagnosis of Parkinson's disease and atypical Parkinsonism remains clinically difficult, especially at the early stage of the disease, since there is a significant overlap of symptoms. Multimodal MRI has significantly improved diagnostic accuracy and
Lydia Chougar +14 more
doaj +1 more source